NCT01046487 2026-03-13
PALANGI3
Centre Oscar Lambret
Phase 1 Completed
Clinical Trials
17 trialsNCT07422805 2026-02-24
ctDNA
Institute of Oncology Ljubljana
Phase NA Completed
NCT01334008 2025-11-24
Study of Circulating Tumoral DNA in Metastatic Choroidal Melanoma
Institut Curie
Phase NA Completed
NCT02849145 2025-09-19
ctDNA R0
Institut Curie
Phase NA Completed
NCT03225365 2025-09-17
IMMUNONIVO
Hospices Civils de Lyon
Phase NA Completed
NCT02831634 2025-09-08
NeoEpitope
Institut Curie
Phase NA Completed
NCT06861647 2025-07-10
iSITE
The Wellcome Sanger Institute
Completed
NCT02278887 2025-03-10
TIL
The Netherlands Cancer Institute
Phase 3 Completed
NCT02875652 2024-01-31
ctDNA MU
Institut Curie
Phase NA Completed
NCT03267381 2023-12-14
Circulating Blood Profile to Predict Recurrence and Response to Systemic Therapy
Vanderbilt-Ingram Cancer Center
Completed
NCT03416933 2023-08-04
OPTIMEL
Institut de Cancérologie de Lorraine
Phase NA Completed
NCT05817149 2023-04-18
Perioperative Examination of Inflammatory Markers in Relation to Sentinel Lymph Node Biopsy in Patients With Melanoma; a Pilot Study
Aalborg University Hospital
Completed
NCT03348891 2021-11-24
MELANFα
Institut Claudius Regaud
Phase NA Completed
NCT02761473 2020-08-20
Cutaneous Mastocytosis in Children: Analysis of Somatic and Germline Mutations
University of Minnesota
Completed
NCT01916135 2020-04-27
PET Imaging of Cancer Patients Using [18F]-SKI-249380, a Radiolabeled Dasatinib-Derivative
Memorial Sloan Kettering Cancer Center
Phase 1 Completed
NCT01528774 2017-07-26
CTC
Comprehensive Cancer Centers of Nevada
Completed
NCT00615095 2011-04-20
Differential Risks for Melanoma: p16 and DNA Repair
Memorial Sloan Kettering Cancer Center
Completed